A1CNOW for Home and Professional Use
Assay, Glycosylated Hemoglobin. 510(k) K033847, from Metrika, Inc. (Sunnyvale, CA). Product code LCP, class 2.
As of Nov 19, 2026, K033847 is an FDA 510(k) held by Metrika, Inc., substantially equivalent on Dec 23, 2003 after 12 days, with no recalls tied to it in FDA's recall database.
- Review time: 12 days
- Recalls: 0
- Cited as a predicate by: 1 device
The A1cNow® test provides quantitative measurement of the percent of glycated hemoglobin (%HbA1c, %A1C) levels in whole blood samples. The test is for home use and professional use for monitoring glycemic control in people with diabetes.
- ImplantmasterK042212 · I-Dent · Oct 21, 2004
- Q-Pad Test SystemK231465 · Qurasense · Dec 6, 2023
- Type
- Special
- Received
- Dec 11, 2003
- Review panel
- Hematology
- Regulation
- 21 CFR 864.7470
One page per 510(k), De Novo and original PMA. Recalls are those FDA's recall database ties to this number; recalls of related devices that cite another number are not shown. Refreshed weekly. Predicates are read by Arca from the text of FDA's 510(k) summary PDFs, most of them scans: a device number counts when the summary names it as a predicate or as the device it is substantially equivalent to. About 97% of those read were right on a sample we checked by hand; summaries from before 2000 often name predicates without a number, so older devices show fewer. Pivotal studies are read by a model from FDA's De Novo decision summaries and PMA SSEDs; a count or result is shown only when its numbers appear in FDA's text. openFDA device 510(k), PMA and recall files